These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2905645

  • 61. Drug-induced and other orofacial-cervical dyskinesias.
    Jankovic J.
    Ann Intern Med; 1981 Jun; 94(6):788-93. PubMed ID: 7015951
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. [Choreo-ballistic status treated by GABA].
    Hashimoto M, Yokota A, Matsuoka S, Shima F.
    No To Hattatsu; 1989 Sep; 21(5):481-5. PubMed ID: 2803801
    [Abstract] [Full Text] [Related]

  • 64. [The electrophysiological approach to tardive dyskinesias].
    Rondot P.
    Encephale; 1988 Sep; 14 Spec No():183-9. PubMed ID: 2905645
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA.
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [Abstract] [Full Text] [Related]

  • 69. [The electrophysiological approach to tardive dyskinesias].
    Rondot P.
    Encephale; 1988 Sep; 14 Spec No():183-9. PubMed ID: 2905645
    [Abstract] [Full Text] [Related]

  • 70. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N, Rondot P, Koutlidis RM.
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [Abstract] [Full Text] [Related]

  • 71. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [Abstract] [Full Text] [Related]

  • 72. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J.
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [Abstract] [Full Text] [Related]

  • 73. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA.
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [Abstract] [Full Text] [Related]

  • 74. [The electrophysiological approach to tardive dyskinesias].
    Rondot P.
    Encephale; 1988 Sep; 14 Spec No():183-9. PubMed ID: 2905645
    [Abstract] [Full Text] [Related]

  • 75. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J.
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.